QinetiQ Annual Report 2017
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
www.qinetiq.com<br />
<strong>QinetiQ</strong><br />
<strong>QinetiQ</strong> Group<br />
Group<br />
plc<br />
plc<br />
<strong>Annual</strong><br />
<strong>Annual</strong><br />
<strong>Report</strong><br />
<strong>Report</strong><br />
and<br />
and<br />
Accounts<br />
Accounts<br />
<strong>2017</strong><br />
<strong>2017</strong><br />
Financial statements<br />
Financial statements<br />
137<br />
137<br />
Group Deferred <strong>Annual</strong> Bonus Plan (DAB)<br />
Under the <strong>QinetiQ</strong> DAB Plan the Group requires certain senior executives to defer part of their annual bonus as shares and be entitled to matching awards to<br />
a maximum of 1:1 based on EPS performance. The number that will vest is dependent on the growth of EPS over the measurement period of three years as<br />
detailed in the <strong>Report</strong> from the Remuneration Committee.<br />
<strong>2017</strong><br />
Number of<br />
matching<br />
shares<br />
2016<br />
Number of<br />
matching<br />
shares<br />
Outstanding at start of year 311,500 464,115<br />
Forfeited during year (294,247) (152,615)<br />
Outstanding at end of year 17,253 311,500<br />
DAB matching shares are equity-settled awards; those outstanding at 31 March <strong>2017</strong> had an average remaining life of 0.3 years (2016: 0.7 years). There are no<br />
shares granted or expressed in the prior year or current year. There is no exercise price for these DAB awards. Of the shares outstanding at the end of the year<br />
nil were exercisable (2016: nil).<br />
Cash Alternative Units (CAUs)<br />
<strong>2017</strong><br />
Number of<br />
awards<br />
2016<br />
Number of<br />
awards<br />
Outstanding at start of year 35,000 290,022<br />
Awarded during year – 20,000<br />
Exercised during the year (35,000) (135,352)<br />
Forfeited during year – (139,670)<br />
Outstanding at end of year – 35,000<br />
CAUs are cash-settled awards which vest over one, two, three and four years from the date of grant. The CAUs have no performance criteria attached, other than<br />
the requirement that the employee remains in employment with the Group. Those awards outstanding at 31 March <strong>2017</strong> had an average remaining life of nil years<br />
(2016: 0.5 years). There is no exercise price for these awards. The fair value of the grants made during the prior year was £2.28 being the Group’s closing share<br />
price on that day. The weighted average share price on the date of exercise was £2.08 (2016: £2.34). The carrying amount of the liability of the grants at the<br />
balance sheet date was nil (2016: nil). Of the awards outstanding at the end of the year nil were exercisable.<br />
Bonus Banking Plan (BBP)<br />
During the year, the Group granted BBP awards to certain senior executives in the UK.<br />
<strong>2017</strong><br />
Number of<br />
awards<br />
2016<br />
Number of<br />
awards<br />
Outstanding at start of year 814,778 330,725<br />
Granted during the year 512,003 493,505<br />
Exercised during the year (534,818) (5,711)<br />
Forfeited during year (5,768) (3,741)<br />
Outstanding at end of year 786,195 814,778<br />
The BBP is a remuneration scheme that runs for four years with effect from 1 April 2014. Refer to the Directors’ Remuneration <strong>Report</strong> for further details. Under the<br />
BBP a contribution will be made by the Company into the participant’s plan account at the start of each plan year. 50% of the value of a participant’s bonus account<br />
will be paid out annually for three years with 100% of the residual value paid out at the end of year four. 50% of the unpaid balance of a participant’s bonus account<br />
will be at risk of forfeiture.<br />
At 31 March <strong>2017</strong>, the awards had an average remaining life of 1.8 years (2016: 2.3 years). There is no exercise price for these awards. The fair value of the awards<br />
at 31 March <strong>2017</strong> was £2.80 (2016: £2.34) being the Group’s 30 day average share price in the period running up to 31 March. Of the awards outstanding at the<br />
end of the year nil were exercisable.<br />
Share-based award pricing – other<br />
Share-based awards that vest based on non-market performance conditions, including certain PSP, RSUs and DAB awards, have been valued at the share price<br />
at grant.